Drug Trial Radar · NCT05755386
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Last checked: Nov 20, 2026Latest source record: Jul 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
106
Planned (sponsor's estimate)
Start
Oct 2, 2023
Primary completion
Oct 27, 2028
Study completion May 31, 2029
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Mar 6, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in idiopathic immune complex mediated membranoproliferative glomerulonephritis.
Conditions
- IC-MPGN
Interventions
PlaceboDrug
Placebo to iptacopan 200mg b.i.d. (Adults 200mg b.i.d; Adolescents 2x 100mg b.i.d)
iptacopanDrug
iptacopan 200 mg b.i.d. (Adults 200mg b.i.d; Adolescents 2x 100mg b.i.d)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Log-transformed ratio to baseline in UPCR (sampled from a 24-hour urine collection) at 6 months.Time frame: 6 months (double-blind)
- Log-transformed ratio to baseline in UPCR at the 18-month visit (each study treatment arm)Time frame: 18 months
- Log-transformed ratio to 12-month visit in UPCR at the 18-month visit in the placebo arm.Time frame: 18 months
Locations
131 sites in 23 countries. Site status is shown where the registry gives one.
Ronald Reagan UCLA Medical Center
Los Angeles, California · Recruiting
Univ Cali Irvine ALS Neuromuscular
Orange, California · Recruiting
UCSF
San Francisco, California · Recruiting
Olive View UCLA Medical Center
Sylmar, California · Recruiting
Childrens Hospital Colorado
Aurora, Colorado · Recruiting
Nicklaus Childrens Hospital
Miami, Florida · Recruiting
Emory University School of Medicine-Winship Cancer Institute
Atlanta, Georgia · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Boston Univ School of Medicine
Boston, Massachusetts · Recruiting
University of Minnesota
Minneapolis, Minnesota · Recruiting
Washington University in St Louis
St Louis, Missouri · Recruiting
University of New Mexico
Albuquerque, New Mexico · Recruiting
Col Uni Med Center New York Presby
New York, New York · Recruiting
University Of Cincinnati
Cincinnati, Ohio · Recruiting
OHSU Dept of Nephrology
Portland, Oregon · Recruiting
Univ of Pennsylvania Medical Center
Philadelphia, Pennsylvania · Recruiting
MUSC Health Lancaster Med Ctr
Lancaster, South Carolina · Recruiting
UT Southwestern Medical Center
Dallas, Texas · Recruiting
Prolato Clinical Research Center
Houston, Texas · Recruiting
Baylor Scott and White Research
Temple, Texas · Recruiting
University of Utah
Salt Lake City, Utah · Recruiting
University of Wisconsin
Madison, Wisconsin · Recruiting
Novartis Investigative Site
Buenos Aires, Argentina · Recruiting
Novartis Investigative Site
CABA, Argentina · Recruiting
Novartis Investigative Site
Santa Fe, Argentina · Recruiting
Novartis Investigative Site
CABA, Buenos Aires, Argentina · Recruiting
Novartis Investigative Site
CABA, Buenos Aires, Argentina · Recruiting
Novartis Investigative Site
Córdoba, Córdoba Province, Argentina · Recruiting
Novartis Investigative Site
Salvador, Brazil · Recruiting
Novartis Investigative Site
Fortaleza, Ceará, Brazil · Recruiting
Novartis Investigative Site
Brasília, Federal District, Brazil · Withdrawn
Novartis Investigative Site
Belo Horizonte, Minas Gerais, Brazil · Recruiting
Novartis Investigative Site
Recife, Pernambuco, Brazil · Recruiting
Novartis Investigative Site
Niterói, Rio de Janeiro, Brazil · Withdrawn
Novartis Investigative Site
Rio de Janeiro, Rio de Janeiro, Brazil · Withdrawn
Novartis Investigative Site
Natal, Rio Grande do Norte, Brazil · Recruiting
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, Brazil · Recruiting
Novartis Investigative Site
Botucatu, São Paulo, Brazil · Recruiting
Novartis Investigative Site
Santo André, São Paulo, Brazil · Recruiting
Novartis Investigative Site
Sao Jose Rio Preto, São Paulo, Brazil · Recruiting
Showing 40 of 131 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.